What to know about GLP-1 | Aging Better

In this week’s episode of Aging Better, host Cyreia Sandlin talks all things GLP-1 with board-certified internist Dr. Paul Bradley.

Dr. Bradley is a practicing board-certified internist and co-founder and Chief Medical Officer of Scripta Insights. He also serves as a Clinical Assistant Professor at Mercer Medical College and holds the title of principal investigator at Meridian Clinical Research in Savannah. Dr. Bradley has led more than 100 pharmaceutical trials, including the Pfizer, Moderna and Novavax COVID-19 vaccine clinical trials.

Dr. Bradley explains how the GLP-1 medications themselves are not new, and he first started prescribing them for diabetics 15 to 20 years from now. These medications have skyrocketed in popularity, as they are now FDA approved for weight loss. A recent Gallup poll estimates 15% of Americans have used a GLP-1 for weight loss.

We’re all aging, so let’s do it smarter! A weekly, practical guide to staying healthy, sharp, and independent as we age—hosted by Cyreia Sandlin.

Stronger years. Smarter choices. / Health, longevity, independence. / Real advice for real life.

Each week, Cyreia talks with local experts and real people about fitness, nutrition, brain health, preventive care, caregiving, and the money choices that shape independence—breaking it into clear takeaways you can use immediately. Cyreia’s asking the questions you might be too scared to ask your doctor, and getting the answers to help you make healthier choices.